Chromatography Septa segmentation by application reveals a portfolio where analytical-scale HPLC dominates with a 42 % revenue share, followed by GC headspace sampling at 27 % and high-throughput LC-MS at 18 %. These niches demand distinct puncture resistance and bleed profiles: HPLC septa must withstand 15 000 psi back-pressures while keeping ghost peaks below 0.5 % area, whereas GC headspace variants prioritize thermal stability to 260 °C to avoid out-gassing that would distort volatile quantification. Preparative purification, capturing 9 % of demand, is the fastest-growing pocket; here, septa diameters scale to 50 mm and the value proposition is cycle life, not absolute inertness. The remaining 4 %—bio-pharma sterile sampling, 2-D-LC valve interfaces, and on-line PAT loops—are micro-segments but command 25-30 % price premiums because they combine USP <661> compliance with low-extractable certification.